New celiac drug trial aims to tame gluten reactions

NCT ID NCT06310291

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage trial tests a new medicine called VTP-1000 in 45 adults with celiac disease. The goal is to see if it is safe and how the body handles it, especially when exposed to gluten. Participants will receive either the drug or a placebo, and some will take a controlled gluten challenge to measure immune response.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CELIAC DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centricity Research

    RECRUITING

    Columbus, Ohio, 43213, United States

  • Clinical Research Institute of Michigan

    RECRUITING

    Clinton Township, Michigan, 48038, United States

  • Clinical Research Partners

    RECRUITING

    Richmond, Virginia, 23226, United States

  • GCP Research

    RECRUITING

    St. Petersburg, Florida, 33705, United States

  • Jacksonville Center for Clinical Research

    RECRUITING

    Jacksonville, Florida, 32216, United States

  • Mayo Clinic

    RECRUITING

    Rochester, Minnesota, 55905, United States

  • NYU Langone - Gastroenterology Associates

    RECRUITING

    New York, New York, 10016, United States

  • North Carolina Clinical Research

    RECRUITING

    Raleigh, North Carolina, 27607, United States

  • PPD Research Unit

    RECRUITING

    Austin, Texas, 78744, United States

  • Parexel EPCU Baltimore

    RECRUITING

    Baltimore, Maryland, 21225, United States

  • Parexel EPCU LA

    RECRUITING

    Los Angeles, California, 91206, United States

  • Peak Gastroenterology Associates

    RECRUITING

    Colorado Springs, Colorado, 80907, United States

  • Vanderbilt University Medical Center

    RECRUITING

    Nashville, Tennessee, 37232, United States

  • Velocity Clinical Research, Salt Lake City

    RECRUITING

    West Jordan, Utah, 84088, United States

  • Velocity Clinical Research, Seattle

    RECRUITING

    Seattle, Washington, 98105, United States

  • West Michigan Clinical Research Center

    RECRUITING

    Wyoming, Michigan, 49159, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.